Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing.

Authors: Huang, Zhong¹ (AUTHOR), Jack, Matthew² (AUTHOR), O'Leary, Kevin J.³ (AUTHOR), Nutescu, Edith A.⁴ (AUTHOR), Chen, Thomas^2,5 (AUTHOR), Ruhnke, Gregory W.⁵ (AUTHOR), George, David^2,6 (AUTHOR), House, Larry K.^2,7 (AUTHOR), Knoebel, Randall^2,8 (AUTHOR), Hartman, Seth⁸ (AUTHOR), Choksi, Anish⁸ (AUTHOR), Yeo, Kiang‐Teck J.^2,6 (AUTHOR), Perera, Minoli A.⁹ (AUTHOR), Ratain, Mark J.^2,7 (AUTHOR), Meltzer, David O.⁵ (AUTHOR), O'Donnell, Peter H.^2,7 (AUTHOR) podonnel@bsd.uchicago.edu

Source: CTS: Clinical & Translational Science. Apr2025, Vol. 18 Issue 4, p1-10. 10p.

Subject Terms: *PHARMACOGENOMICS, *CLINICAL decision support systems, *MEDICAL care use, *DRUG prescribing, *PATIENT care, *HEALTH care teams, *PREDICTION models

Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community.

Authors: Wichman, Madeline L.^1,2 (AUTHOR), Wall, Daniela M.^1,2 (AUTHOR), Garcia Mota, Suzanna S.³ (AUTHOR), Killam, Shayna R.^1,2 (AUTHOR), Brown, Karen E.^1,2 (AUTHOR), Aagaard, Kaja⁴ (AUTHOR), Swaney, Juanita⁵ (AUTHOR), Muzquiz, LeeAnna I.⁵ (AUTHOR), Corum, Bernadette N.⁵ (AUTHOR), Claw, Katrina G.⁴ (AUTHOR), Woodahl, Erica L.^1,2 (AUTHOR) erica.woodahl@umontana.edu

Source: CTS: Clinical & Translational Science. Mar2025, Vol. 18 Issue 3, p1-10. 10p.

Subject Terms: *PHARMACOGENOMICS, *SMOKING cessation, *INDIGENOUS peoples, *RESEARCH ethics, *QUESTIONNAIRES, *COMMUNITY involvement, *HEALTH education, *POOR communities

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.

Authors: Alexander, Marliese^1,2 (AUTHOR) marliese.alexander@unimelb.edu.au, Lim, Chiao Xin^3,4 (AUTHOR), Lingaratnam, Senthil^1,2 (AUTHOR), Glewis, Sarah^1,2 (AUTHOR), Wickens, Joanne³ (AUTHOR), Hird, Abbey³ (AUTHOR), Chen, Zi Yue³ (AUTHOR), Bozkurt, Alistair³ (AUTHOR), Khot, Amit^2,5 (AUTHOR), Routledge, David^2,5 (AUTHOR), Harris, Sam⁶ (AUTHOR), Underhill, Craig^7,8,9 (AUTHOR), Whitechurch, Ashley⁵ (AUTHOR), Leong, Lydia¹ (AUTHOR), Pergolini, Marcus¹ (AUTHOR), Rowan, Gail¹ (AUTHOR), Samo, Monnette¹ (AUTHOR), Georgiou, Chloe⁶ (AUTHOR), Savas, Peter^2,10 (AUTHOR), Devine, Jenny^11,12 (AUTHOR)

Source: CTS: Clinical & Translational Science. Mar2025, Vol. 18 Issue 3, p1-7. 7p.

Subject Terms: *PHARMACOGENOMICS, *CANCER treatment, *MEDICAL personnel, *CONSUMER attitudes, *NEEDS assessment, *ATTITUDE (Psychology), *MEDICAL protocols, *QUESTIONNAIRES

A Randomized Hybrid‐Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx‐ACT) Trial.

Authors: Smith, D. Max^1,2 (AUTHOR) max.smith@medstar.net, Beyene, Rut¹ (AUTHOR), Kolm, Paul¹ (AUTHOR), Young, Theresa A.¹ (AUTHOR), Zifa, Sara¹ (AUTHOR), Natividad, Victoria¹ (AUTHOR), Licata, Andrea¹ (AUTHOR), Podolsky, Robert H.¹ (AUTHOR), Moore, Troy³ (AUTHOR), Walsh, Richard¹ (AUTHOR), Deva, Shikha¹ (AUTHOR), Walker, Alexander D.^1,2 (AUTHOR), Jacobs, Michael B.¹ (AUTHOR), Peshkin, Beth N.^1,4 (AUTHOR), Swain, Sandra M.^1,2 (AUTHOR)

Source: CTS: Clinical & Translational Science. Feb2025, Vol. 18 Issue 2, p1-10. 10p.

Subject Terms: *PHARMACOGENOMICS, *CHRONIC pain, *THERAPEUTICS, *CYTOCHROME P-450 CYP2D6, *CLINICAL trials, *PAIN management, *PRIMARY care, *PAIN threshold

Real‐World Utilization of Medications With Pharmacogenetic Recommendations in Older Adults: A Scoping Review.

Authors: Ianni, Bella D.^1,2,3 (AUTHOR), Yiu, Chin Hang^1,2 (AUTHOR), Tan, Edwin C. K.^1,2 (AUTHOR), Lu, Christine Y.^1,2,3 (AUTHOR) christine.lu@sydney.edu.au

Source: CTS: Clinical & Translational Science. Feb2025, Vol. 18 Issue 2, p1-15. 15p.

Subject Terms: *PHARMACOGENOMICS, *OLDER people, *MEDICAL care, *DRUG utilization, *MEDICAL protocols, *INSURANCE, *DRUG interactions

Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA): Actionability and Comparison Across Other Regulatory Agencies.

Authors: Moschella, Antonino¹ (AUTHOR), Mourou, Soumaya² (AUTHOR), Perfler, Samantha³ (AUTHOR), Zoroddu, Enrico² (AUTHOR), Bezzini, Daiana⁴ (AUTHOR), Soru, Dorian⁵ (AUTHOR), Trignano, Claudia² (AUTHOR), Miozzo, Monica⁶ (AUTHOR), Squassina, Alessio⁷ (AUTHOR), Cecchin, Erika³ (AUTHOR) ececchin@cro.it, Floris, Matteo² (AUTHOR)

Source: CTS: Clinical & Translational Science. Feb2025, Vol. 18 Issue 2, p1-9. 9p.

Subject Terms: *PHARMACOGENOMICS, *DRUG labeling, *FEASIBILITY studies, *PRODUCT attributes, *GOVERNMENT agencies

The needs and gaps in pharmacogenomics knowledge and education among healthcare professionals in Malaysia: A multisite Delphi study.

Authors: Omran, Safa¹ (AUTHOR), Leong, Siew Lian¹ (AUTHOR), Blebil, Ali^1,2 (AUTHOR), Mohan, Devi³ (AUTHOR), Ang, Wei Chern^4,5 (AUTHOR), Teoh, Siew Li¹ (AUTHOR) teoh.siew.li@monash.edu

Source: CTS: Clinical & Translational Science. Nov2024, Vol. 17 Issue 11, p1-11. 11p.

Subject Terms: *MEDICAL personnel, *PHARMACOGENOMICS, *JUDGMENT sampling, *SAMPLING methods, *STATISTICS, *KNOWLEDGE gap theory

Precision Medicine: Unveiling Progress Amidst Challenges.

Authors: Yadav, Piyush¹ (AUTHOR), Sreelakshmi, M¹ (AUTHOR) sreelakshmi_710@yahoo.in, Chauhan, Vikas² (AUTHOR), Mishra, Ritu¹ (AUTHOR)

Source: International Journal of Pharmaceutical Investigation. Oct-Dec2024, Vol. 14 Issue 4, p1010-1018. 9p.

Subject Terms: *PHARMACOGENOMICS, *PSYCHOLOGICAL factors, *DISEASE progression, *PATIENT care, *INDIVIDUALIZED medicine, *GENOTYPES

The polygenic implication of clopidogrel responsiveness: Insights from platelet reactivity analysis and next-generation sequencing.

Authors: Echeverría, Omar¹ (AUTHOR), Angulo-Aguado, Mariana¹ (AUTHOR), Vela, Ricardo¹ (AUTHOR), Calderón-Ospina, Carlos¹ (AUTHOR), Parra, Katherine² (AUTHOR), Contreras, Nora¹ (AUTHOR), Morel, Adrien¹ (AUTHOR), Cabrera, Rodrigo¹ (AUTHOR), Restrepo, Carlos¹ (AUTHOR), Ramírez-Santana, Carolina³ (AUTHOR), Ortega-Recalde, Oscar^1,4 (AUTHOR), Rojas-Quintana, Manuel Eduardo^3,5 (AUTHOR), Murcia, Luisa² (AUTHOR), Gaviria-Sabogal, Cristian Camilo¹ (AUTHOR), Valero, Nattaly¹ (AUTHOR), Fonseca-Mendoza, Dora Janeth¹ (AUTHOR) dora.fonseca@urosario.edu.co

Source: PLoS ONE. 7/11/2024, Vol. 19 Issue 7, p1-25. 25p.

Subject Terms: *PHARMACOGENOMICS, *NUCLEOTIDE sequencing, *CLOPIDOGREL, *DISEASE risk factors, *SINGLE nucleotide polymorphisms, *BLOOD platelets, *BLOOD platelet aggregation

QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.

Authors: Abdel‐latif, Rania¹ (AUTHOR) rabdellatif@qf.org.qa, Badji, Radja¹ (AUTHOR), Mohammed, Shaban² (AUTHOR), Al‐Muftah, Wadha¹ (AUTHOR), Mbarek, Hamdi¹ (AUTHOR), Darwish, Dima¹ (AUTHOR), Assaf, Duha¹ (AUTHOR), Al‐Badriyeh, Daoud³ (AUTHOR), Elewa, Hazem³ (AUTHOR), Afifi, Nahla⁴ (AUTHOR), Masoodi, Naseer Ahmad⁵ (AUTHOR), Omar, Amr Salah⁶ (AUTHOR), Al Suwaidi, Jassim⁶ (AUTHOR), Bujassoum, Salha⁷ (AUTHOR), Al Hail, Moza² (AUTHOR), Ismail, Said I.¹ (AUTHOR), Althani, Asma⁸ (AUTHOR)

Source: CTS: Clinical & Translational Science. Jun2024, Vol. 17 Issue 6, p1-13. 13p.

Subject Terms: *MEDICAL research, *PHARMACOGENOMICS, *MEDICAL personnel, *CLINICAL medicine, *GENETIC profile

A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data.

Authors: John, Shobana^1,2 (AUTHOR), Klumsathian, Sommon³ (AUTHOR), Own‐eium, Paravee³ (AUTHOR), Eu‐ahsunthornwattana, Jakris⁴ (AUTHOR), Sura, Thanyachai⁵ (AUTHOR), Dejsuphong, Donniphat⁶ (AUTHOR), Sritara, Piyamitr⁷ (AUTHOR), Vathesatogkit, Prin⁷ (AUTHOR), Thongchompoo, Nartthawee³ (AUTHOR), Thabthimthong, Wiphaporn³ (AUTHOR), Teerakulkittipong, Nuttinee⁸ (AUTHOR), Chantratita, Wasun³ (AUTHOR), Sukasem, Chonlaphat^1,2,8,9,10 (AUTHOR) chonlaphat.suk@mahidol.ac.th

Source: CTS: Clinical & Translational Science. Jun2024, Vol. 17 Issue 6, p1-20. 20p.

Subject Terms: *PHARMACOGENOMICS, *WHOLE genome sequencing, *PHENOTYPES, *THAI people, *DATABASES, *GENETIC variation, *SHORT tandem repeat analysis

Geographic Terms: THAILAND

Rationale and design for a pragmatic randomized trial to assess gene‐based prescribing for SSRIs in the treatment of depression.

Authors: Hines, Lindsay J.^1,2 (AUTHOR) lindsay.hines@sanfordhealth.org, Wilke, Russell A.³ (AUTHOR), Myers, Rachel⁴ (AUTHOR), Mathews, Carol A.^5,6 (AUTHOR), Liu, Michelle⁷ (AUTHOR), Baye, Jordan F.⁸ (AUTHOR), Petry, Natasha^9,10 (AUTHOR), Cicali, Emily J.¹¹ (AUTHOR), Duong, Benjamin Q.¹² (AUTHOR), Elwood, Erica¹¹ (AUTHOR), Hulvershorn, Leslie¹³ (AUTHOR), Nguyen, Khoa¹¹ (AUTHOR), Ramos, Michelle¹⁴ (AUTHOR), Sadeghpour, Azita¹⁵ (AUTHOR), Wu, R. Ryanne¹⁵ (AUTHOR), Williamson, Lloyda¹⁶ (AUTHOR), Wiisanen, Kristin¹¹ (AUTHOR), Voora, Deepak¹⁵ (AUTHOR), Singh, Rajbir¹⁷ (AUTHOR), Blake, Kathryn V.¹⁸ (AUTHOR)

Source: CTS: Clinical & Translational Science. Jun2024, Vol. 17 Issue 6, p1-15. 15p.

Subject Terms: *ANTIDEPRESSANTS, *PHARMACOGENOMICS, *DULOXETINE, *CLINICAL decision support systems, *DRUG side effects, *SEROTONIN uptake inhibitors, *MENTAL depression, *DRUG interactions

Multivariate Bayesian structured variable selection for pharmacogenomic studies.

Authors: Zhao, Zhi^1,2 (AUTHOR) zhi.zhao@medisin.uio.no, Banterle, Marco³ (AUTHOR), Lewin, Alex³ (AUTHOR), Zucknick, Manuela¹ (AUTHOR)

Source: Journal of the Royal Statistical Society: Series C (Applied Statistics). Mar2024, Vol. 73 Issue 2, p420-443. 24p.

Subject Terms: Markov random fields, Pharmacogenomics, Antineoplastic agents, Multiomics, Cancer cells, Medical screening

Innovative Machine Learning Framework for Anticipating Synergistic Effects in Cancer Drug Therapy

Authors: Patil, Shrinivas, Ashok, Bhandari Mahesh, Gajendran, P., Singh, Takveer, S, Hemalatha, Mishra, Mukul

Source: 2024 IEEE 4th International Conference on ICT in Business Industry & Government (ICTBIG) ICT in Business Industry & Government (ICTBIG), 2024 IEEE 4th International Conference on. :1-6 Dec, 2024

Relation: 2024 IEEE 4th International Conference on ICT in Business Industry & Government (ICTBIG)

Advancing Patient-Centric Care Through Genomic Data and Deep Learning

Authors: Srimlika, Nomula, Sriram, Lokesh, Sharma, Vandana, Mishra, Sushruta, Alkhayyat, Ahmed

Source: 2024 IEEE 4th International Conference on ICT in Business Industry & Government (ICTBIG) ICT in Business Industry & Government (ICTBIG), 2024 IEEE 4th International Conference on. :1-6 Dec, 2024

Relation: 2024 IEEE 4th International Conference on ICT in Business Industry & Government (ICTBIG)

Artificial Intelligence in Personalized Medicine: A Survey on FuncPredict: AI Driven Genetic Variant Analysis

Authors: V, Dhanapandi, G, Mahendran, S A, Nivetha, M, Sonali, D P, Susmitha

Source: 2024 3rd International Conference on Automation, Computing and Renewable Systems (ICACRS) Automation, Computing and Renewable Systems (ICACRS), 2024 3rd International Conference on. :999-1005 Dec, 2024

Relation: 2024 3rd International Conference on Automation, Computing and Renewable Systems (ICACRS)

Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity

Authors: Agapito, Giuseppe, Milano, Marianna, Scionti, Francesca, Staropoli, Nicoletta, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Cannataro, Mario, Arbitrio, Mariamena

Source: 2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) Bioinformatics and Biomedicine (BIBM), 2024 IEEE International Conference on. :4331-4337 Dec, 2024

Relation: 2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)

A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.

Authors: Lingaratnam, Senthil^1,2,3 (AUTHOR) Senthil.lingaratnam@petermac.org, Shah, Mahek⁴ (AUTHOR), Nicolazzo, Joseph³ (AUTHOR), Michael, Michael^2,5 (AUTHOR), Seymour, John F.^2,6 (AUTHOR), James, Paul⁷ (AUTHOR), Lazarakis, Smaro⁸ (AUTHOR), Loi, Sherene^2,9 (AUTHOR), Kirkpatrick, Carl M. J.³ (AUTHOR)

Source: CTS: Clinical & Translational Science. May2024, Vol. 17 Issue 5, p1-23. 23p.

Subject Terms: *SYMPTOM burden, *PHARMACOGENOMICS, *CANCER patients, *RANDOM effects model, *GERM cells

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Authors: Gambari, Roberto¹ (AUTHOR) gam@unife.it, Waziri, Aliyu Dahiru² (AUTHOR) aliwazeery@gmail.com, Goonasekera, Hemali³ (AUTHOR) hemali@anat.cmb.ac.lk, Peprah, Emmanuel⁴ (AUTHOR) ep91@nyu.edu

Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 8, p4263. 26p.

Subject Terms: *PHARMACOGENOMICS, *GLOBIN genes, *MEDICAL research, *GENE expression, *FETAL hemoglobin, *CLINICAL medicine

Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers.

Authors: Basu, Aniruddha¹ (AUTHOR), Dutta, Atanu Kumar² (AUTHOR), Bagepally, Bhavani Shankara³ (AUTHOR), Das, Saibal^4,5 (AUTHOR) saibal.das@icmr.gov.in, Cherian, Jerin Jose^5,6 (AUTHOR), Roy, Sudipto⁶ (AUTHOR), Maurya, Pawan Kumar⁴ (AUTHOR), Saha, Indranil⁴ (AUTHOR), Sukumaran, Deepasree⁷ (AUTHOR), Rina, Kumari¹ (AUTHOR), Mandal, Sucharita¹ (AUTHOR), Sarkar, Sukanto¹ (AUTHOR), Kalita, Manoj⁴ (AUTHOR), Bhowmik, Kalyan⁴ (AUTHOR), Saha, Asim⁴ (AUTHOR), Chakrabarti, Amit⁴ (AUTHOR)

Source: PLoS ONE. 4/10/2024, Vol. 19 Issue 4, p1-15. 15p.

Subject Terms: *OLANZAPINE, *PHARMACOGENOMICS, *MEDICAL protocols, *RESEARCH protocols, *SINGLE nucleotide polymorphisms, *COST effectiveness, *SCHIZOPHRENIA

Geographic Terms: INDIA